Tough day at the Lace! Phase 1 MMED surging..OH my!!! ; - )Good day for MindMEd though
The phase 1 is primed and at the ready!
Up at 125M today on the phase 1 start up news...that is about 4 TIMES the Lace value ; - )
MindMed is undertaking a phase 1 clinical trial to evaluate if MDMA, when balanced and used in combination with LSD, can help offset some of the known potential unpleasant effects of LSD that occur in therapy or clinical settings. MindMed is interested in understanding how to balance both MDMA and LSD in a cohesive way to create better patient outcomes and develop more advanced psychedelic-assisted therapies as MindMed expands both its research and development and commercial drug development pipeline. The study is anticipated to take around one year to complete.
Dr. Miri Halperin Wernli, president of MindMed, added: "I believe that, when LSD and MDMA are taken together, they have exceptional potential to open a window into our mind which will awaken it to new levels of awareness by changing the fluidity of the state of consciousness, amplifying changed perceptions, intensifying emotions and stimulating novel thoughts. It is like a gateway to a multidimensional universe."